Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.
Consun Pharmaceutical Group Limited, a company incorporated in the Cayman Islands, has announced proposed amendments to its existing memorandum and articles of association. These amendments aim to allow the company to hold and dispose of repurchased shares as treasury shares, in line with Cayman Islands law and recent changes to the Hong Kong Stock Exchange’s listing rules. The changes are pending shareholder approval at an upcoming extraordinary general meeting.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Average Trading Volume: 3,449,066
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.33B
For an in-depth examination of 1681 stock, go to TipRanks’ Overview page.